Analyze Diet
Animals : an open access journal from MDPI2023; 13(12); doi: 10.3390/ani13121984

Seroprevalence of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum Infections in German Horses.

Abstract: There are limited data on Lyme borreliosis (LB), a tick-borne disease caused by the Borrelia burgdorferi sensu lato complex, in horses. Seropositivity is not necessarily associated with clinical disease. Data on seropositivity against Borrelia burgdorferi and Anaplasma phagocytophilum in German horses are sparse. Therefore, serum samples from horses (n = 123) suspected of having Lyme borreliosis and clinically healthy horses (n = 113) from the same stables were tested for specific antibodies against Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum. The samples were screened for antibodies against Borrelia burgdorferi (ELISA and an IgG line immunoblot assay). Furthermore, the samples were examined for antibodies against B. burgdorferi and Anaplasma phagocytophilum with a validated rapid in-house test (SNAP® 4Dx Plus® ELISA). The clinical signs of suspect horses included lameness (n = 36), poor performance (n = 19), and apathy (n = 12). Twenty-three percent (n = 26) of suspect horses and 17% (n = 18) of clinically healthy horses were seropositive for having a Borrelia burgdorferi sensu lato infection (p = 0.371), showing that the detection of specific antibodies against B. burgdorferi alone is not sufficient for a diagnosis of equine LB. Anaplasma phagocytophilum seropositivity and seropositivity against both pathogens was 20%/6% in suspect horses and 16%/2% in the clinically healthy population, showing only minor differences (p = 0.108). Unspecific testing for antibodies against B. burgdorferi without clinical suspicion of Lyme borreliosis is not recommended since the clinical relevance of seropositivity against Borrelia burgdorferi sensu lato remains to be elucidated.
Publication Date: 2023-06-14 PubMed ID: 37370494PubMed Central: PMC10295046DOI: 10.3390/ani13121984Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study assesses the prevalence of Lyme borreliosis (LB) and Anaplasma phagocytophilum infections in German horses indicating that the presence of antibodies specific to these infections doesn’t guarantee a diagnosis of LB. The research reveals a minor difference in seropositivity between suspected and clinically healthy horses, advising against nonspecific tests for LB antibodies without clinical suspicion.

Overview of Methodology and Findings

  • The study used blood samples from 123 horses suspected of having Lyme borreliosis (LB) and 113 from those clinically healthy but living in the same stables.
  • These samples were subjected to two tests: an enzyme-linked immunoassay (ELISA) and an immunoglobulin G (IgG) line immunoblot assay. These are standard diagnostic tests used to identify specific antibodies against Borrelia burgdorferi sensu lato—the bacteria complex that causes LB—and Anaplasma phagocytophilum—another tick-borne bacteria that can infect horses.
  • In addition to these, a validated rapid in-house test (SNAP 4Dx Plus ELISA) was also used. This test is particularly useful for identifying antibodies against both mentioned pathogens.
  • Among the horses suspected of having LB, the most common symptoms were lameness, poor performance, and apathy.
  • Interestingly, the research found that 23% of the suspect horses and 17% of the clinically healthy horses tested positive for Borrelia burgdorferi sensu lato infection. This presented a conclusion that the presence of specific antibodies alone is not sufficient to diagnose LB in horses.
  • A similar insignificant difference was observed when testing for Anaplasma phagocytophilum, with the seropositivity in suspect horses being 20% and in healthy horses being 16%.

Implications of the Findings

  • The study suggests that testing for antibodies against Borrelia burgdorferi sensu lato without clear clinical suspicion of LB is not recommended. This is due to the detected seropositivity even in clinically healthy horses.
  • This implies that the clinical significance or consequences of seropositivity against this pathogen in horses is not definitively understood and remains to be clarified.
  • The minor difference in seropositivity rates between suspect and healthy horses is another crucial point that needs further investigation. This result could either point to a high exposure rate in all horses or reflect the unspecific clinical presentation and failure to correctly identify affected horses.

Cite This Article

APA
Gehlen H, Inerle K, Bartel A, Stöckle SD, Ulrich S, Briese B, Straubinger RK. (2023). Seroprevalence of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum Infections in German Horses. Animals (Basel), 13(12). https://doi.org/10.3390/ani13121984

Publication

ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 13
Issue: 12

Researcher Affiliations

Gehlen, Heidrun
  • Equine Clinic: Surgery and Radiology, Freie Universitaet Berlin, 14163 Berlin, Germany.
Inerle, Katharina
  • Equine Clinic: Surgery and Radiology, Freie Universitaet Berlin, 14163 Berlin, Germany.
Bartel, Alexander
  • Institute for Veterinary Epidemiology and Biostatistics, Freie Universitaet Berlin, 14163 Berlin, Germany.
Stöckle, Sabita Diana
  • Equine Clinic: Surgery and Radiology, Freie Universitaet Berlin, 14163 Berlin, Germany.
Ulrich, Sebastian
  • Chair of Bacteriology and Mycology, Department of Veterinary Sciences, Faculty of Veterinary Medicine, Institute for Infectious Diseases and Zoonosis, Ludwig-Maximilians-Universität, 85764 Oberschleißheim, Germany.
Briese, Beatrice
  • Equine Clinic: Surgery and Radiology, Freie Universitaet Berlin, 14163 Berlin, Germany.
Straubinger, Reinhard K
  • Chair of Bacteriology and Mycology, Department of Veterinary Sciences, Faculty of Veterinary Medicine, Institute for Infectious Diseases and Zoonosis, Ludwig-Maximilians-Universität, 85764 Oberschleißheim, Germany.

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 103 references
  1. Burgess E.C, Gillette D, Pickett J.P. Arthritis and panuveitis as manifestations of Borrelia burgdorferi infection in a Wisconsin pony. J. Am. Vet. Med. Assoc. 1986;189:1340–1342.
    pubmed: 3793582
  2. Burgess E.C, Mattison M. Encephalitis associated with Borrelia burgdorferi infection in a horse. J. Am. Vet. Med. Assoc. 1987;191:1457–1458.
    pubmed: 3692996
  3. Hahn C.N, Mayhew I.G, Whitwell K.E, Smith K.C, Carey D, Carter S.D, Read R.A. A possible case of Lyme borreliosis in a horse in the UK. Equine Vet. J. 1996;28:84–88.
  4. Karlsson M, Hovind-Hougen K, Svenungsson B, Stiernstedt G. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J. Clin. Microbiol. 1990;28:473–479.
    doi: 10.1128/jcm.28.3.473-479.1990pmc: PMC269647pubmed: 2324275google scholar: lookup
  5. Divers T.J, Gardner R.B, Madigan J.E, Witonsky S.G, Bertone J.J, Swinebroad E.L, Schutzer S.E, Johnson A.L. Borrelia burgdorferi Infection and Lyme Disease in North American Horses: A Consensus Statement. J. Vet. Intern. Med. 2018;32:617–632.
    doi: 10.1111/jvim.15042pmc: PMC5866975pubmed: 29469222google scholar: lookup
  6. Burgess B. Lyme Disease in horses. Can. Vet. J. 1988;29:393–394.
    pmc: PMC1680893pubmed: 17423037
  7. Magnarelli L.A, Anderson J.F, Shaw E, Post J.E, Palka F.C. Borreliosis in equids in northeastern United States. Am. J. Vet. Res. 1988;49:359–362.
    pubmed: 3282461
  8. Magnarelli L.A, Anderson J.F. Class-specific and polyvalent enzyme-linked immunosorbent assays for detection of antibodies to Borrelia burgdorferi in equids. J. Am. Vet. Med. Assoc. 1989;195:1365–1368.
    pubmed: 2684937
  9. Browning A, Carter S.D, Barnes A, May C, Bennett D. Lameness associated with Borrelia burgdorferi infection in the horse. Vet. Rec. 1993;132:610–611.
    doi: 10.1136/vr.132.24.610pubmed: 8337810google scholar: lookup
  10. Liebisch G, Assmann G, Liebisch A. Infektion mit Borrelia burgdorferi sl als Krankheitsursache der Lyme-Borreliose bei Pferden in Deutschland. Prakt. Tierarzt. 1999;80:498–516.
  11. Manion T.B, Bushmich S.L, Khan M.I, Dinger J, Werner H, Mittel L, Laurendeau M, Reilly M. Suspected clinical Lyme disease in horses: Serological and antigen testing differences between clinically ill and clinically normal horses from an endemic region. J. Equine Vet. Sci. 2001;21:229–234.
  12. Durrani A.Z, Goyal S.M, Kamal N. Retrospective study on seroprevalence of Borrelia burgdorferi antibodies in horses in Minnesota. J. Equine Vet. Sci. 2011;31:427–429.
  13. Laus F, Veronesi F, Passamonti F, Paggi E, Cerquetella M, Hyatt D, Tesei B, Fioretti D.P. Prevalence of tick borne pathogens in horses from Italy. J. Vet. Med. Sci. 2013;75:715–720.
    doi: 10.1292/jvms.12-0449pubmed: 23328633google scholar: lookup
  14. Funk R, Pleasant R, Witonsky S, Reeder D, Werre S, Hodgson D. Seroprevalence of Borrelia burgdorferi in horses presented for Coggins testing in Southwest Virginia and change in positive test results approximately 1 year later. J. Vet. Intern. Med. 2016;30:1300–1304.
    doi: 10.1111/jvim.13973pmc: PMC5089602pubmed: 27214745google scholar: lookup
  15. Maloney E, Lindenmayer J. Seroprevalence and Clinical Signs of Lyme Disease in Cape Cod Horses. Equine Pract. 1992.
  16. Lindenmayer J, Weber M, Onderdonk A. Borrelia burgdorferi infection in horses. J. Am. Vet. Med. Assoc. 1989;194:1384.
    pubmed: 2722625
  17. Marcus L, Patterson M, Gilfillan R, Urband P. Antibodies to Borrelia burgdorferi in New England horses: Serologic survey. Am. J. Vet. Res. 1985;46:2570–2571.
    pubmed: 4083595
  18. Cohen D, Bosler E.M, Bernard W, Meirs D, Eisner R, Schulze T.L. Epidemiologic studies of Lyme disease in horses and their public health significance. Ann. N. Y. Acad. Sci. 1988;539:244–257.
  19. Bernard W, Cohen D, Bosler E, Zamos D. Serologic survey for Borrelia burgdorferi antibody in horses referred to a mid-Atlantic veterinary teaching hospital. J. Am. Vet. Med. Assoc. 1990;196:1255–1258.
    pubmed: 2332371
  20. Cohen N, Heck F, Heim B, Flad D, Bosler E, Cohen D. Seroprevalence of antibodies to Borrelia burgdorferi in a population of horses in central Texas. J. Am. Vet. Med. Assoc. 1992;201:1030–1034.
    pubmed: 1429127
  21. Käsbohrer A, Schönberg A. Serologische Untersuchungen zum Vorkommen von Borrelia burgdorferi bei Haustieren in Berlin (West). Berl. Munch. Tierarztl. Wochenschr. 1990;103:374–378.
    pubmed: 2268252
  22. Tasai M, Takashima I, Kariwa H, Hashimoto N, Kondo T, Sugiura T, Kamada M. Serological survey of Lyme borreliosis in horses in Japan by immunofluorescent antibody test and fluorescent enzyme-linked immunosorbent assay. Bull. Equine Res. Inst. 1993;1993:37–42.
  23. Gerhards H, Wollanke B. Antibody titers against Borrelia in horses in serum and in eyes and occurrence of equine recurrent uveitis. Berl. Munch. Tierarztl. Wochenschr. 1996;109:273–278.
    pubmed: 9005836
  24. Carter S, May C, Barnes A, Bennett D. Borrelia burgdorferi infection in UK horses. Equine Vet. J. 1994;26:187–190.
  25. Magnarelli L.A, IJdo J.W, Van Andel A.E, Wu C, Padula S.J, Fikrig E. Serologic confirmation of Ehrlichia equi and Borrelia burgdorferi infections in horses from the northeastern United States. J. Am. Vet. Med. Assoc. 2000;217:1045–1050.
    doi: 10.2460/javma.2000.217.1045pubmed: 11019714google scholar: lookup
  26. Štefančíková A, Štepánová G, Pet’ko B, Nadzamová D, Szestáková E, Škardová I, Leinstein R. Prevalence of antibodies to Borrelia burgdorferi in horses of East Slovakia. Vet. Med. 2000;45:227–231.
  27. Stefancikova A, Adaszek Ł, Pet’ko B, Winiarczyk S, Dudinak V. Serological evidence of Borrelia burgdorferi sensu lato in horses and cattle from Poland and diagnostic problems of Lyme borreliosis. Ann. Agric. Environ. Med. AAEM. 2008;15:37–43.
    pubmed: 18581977
  28. Egenvall A, Franzén P, Gunnarsson A, Engvall E.O, Vågsholm I, Wikström U.-B, Artursson K. Cross-sectional study of the seroprevalence to Borrelia burgdorferi sensu lato and granulocytic Ehrlichia spp. and demographic, clinical and tick-exposure factors in Swedish horses. Prev. Vet. Med. 2001;49:191–208.
    doi: 10.1016/S0167-5877(01)00187-8pubmed: 11311953google scholar: lookup
  29. Salinas-Mélendez J, de la Garza S.G, Riojas-Valdés V, González A.W, Avalos-Ramírez R. Antibody detection against Borrelia burgdorferi in horses located in the suburban areas of Monterrey, Nuevo León. Rev. Latinoam. Microbiol. 2001;43:161–164.
    pubmed: 17061503
  30. Müller I, Khanakah G, Kundi M, Stanek G. Horses and Borrelia: Immunoblot patterns with five Borrelia burgdorferi sensu lato strains and sera from horses of various stud farms in Austria and from the Spanish Riding School in Vienna. Int. J. Med. Microbiol. 2002;291:80–87.
    doi: 10.1016/S1438-4221(02)80017-0pubmed: 12141766google scholar: lookup
  31. Schoenert S, Grabner A, Heidrich J, Schoenberg A, Noeckler K, Bahn P, Luge E, Brem S, Mueller W. Lyme disease in the horse? Comparative studies of direct and indirect testing for Borrelia burgdorferi. Prakt. Tierarzt. 2002;83:1064–1068.
  32. Bhide M, Yilmaz Z, Golcu E, Torun S, Mikula I. Seroprevalence of anti-Borrelia burgdorferi antibodies in dogs and horses in Turkey. Ann. Agric. Environ. Med. 2008;15:85–90.
    pubmed: 18581984
  33. Hansen M.G, Christoffersen M, Thuesen L.R, Petersen M.R, Bojesen A.M. Seroprevalence of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in Danish horses. Acta Vet. Scand. 2010;52:1–6.
    pmc: PMC2818635pubmed: 20082693
  34. Kiss T, Cadar D, Krupaci A.F, Bordeanu A, Brudaşcă G.F, Mihalca A.D, Mircean V, Gliga L, Dumitrache M.O, Spînu M. Serological reactivity to Borrelia burgdorferi sensu lato in dogs and horses from distinct areas in Romania. Vector-Borne Zoonotic Dis. 2011;11:1259–1262.
    doi: 10.1089/vbz.2010.0254pubmed: 21612524google scholar: lookup
  35. Ebani V.V, Bertelloni F, Pinzauti P, Cerri D. Seroprevalence of Leptospira spp. and Borrelia burgdorferi sensu lato in Italian horses. Ann. Agric. Environ. Med. 2012;19:237–240.
    pubmed: 22742794
  36. Veronesi F, Laus F, Passamonti F, Tesei B, Fioretti D.P, Genchi C. Occurrence of Borrelia lusitaniae infection in horses. Vet. Microbiol. 2012;160:535–538.
    doi: 10.1016/j.vetmic.2012.06.029pubmed: 22789679google scholar: lookup
  37. Lee S.-H, Yun S.-H, Choi E, Park Y.-S, Lee S.-E, Cho G.-J, Kwon O.-D, Kwak D. Serological detection of Borrelia burgdorferi among horses in Korea. Korean J. Parasitol. 2016;54:97.
    doi: 10.3347/kjp.2016.54.1.97pmc: PMC4792323pubmed: 26951987google scholar: lookup
  38. Meersschaert C, Cerri S, Pitel P.-H, De Waele V, Hendrickx G, Amory H. Seroprevalence of Borrelia burgdorferi in horses in the southern part of Belgium: A “one health” driven study; Proceedings of the AESA Congress; Liege, Belgium. 7–9 September 2016.
  39. Craft J.E, Grodzicki R.L, Steere A.C. Antibody response in Lyme disease: Evaluation of diagnostic tests. J. Infect. Dis. 1984;149:789–795.
    doi: 10.1093/infdis/149.5.789pubmed: 6373966google scholar: lookup
  40. Christen H.J, Hanefeld F, Eiffert H, Thomssen R. Epidemiology and clinical manifestations of Lyme borreliosis in childhood: A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr. 1993;82:1–76.
  41. Frey A.B, Rao T.D. Single exposure of mice to Borrelia burgdorferi elicits immunoglobulin G antibodies characteristic of secondary immune response without production of interleukin-4 by immune T cells. Infect. Immun. 1995;63:2596–2603.
  42. Dattwyler R.J, Volkman D.J, Luft B.J. Immunologic Aspects of Lyme Borreliosis. Rev. Infect. Dis. 1989;11:S1494–S1498.
  43. Hubálek Z, Halouzka J. Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review. Eur. J. Epidemiol. 1997;13:951–957.
    doi: 10.1023/A:1007426304900pubmed: 9476827google scholar: lookup
  44. Anderson J.F. Epizootiology of Borrelia in Ixodes tick vectors and reservoir hosts. Rev. Infect. Dis. 1989;11((Suppl. S6)):S1451–S1459.
  45. Lane R.S, Piesman J, Burgdorfer W. Lyme borreliosis: Relation of its causative agent to its vectors and hosts in North America and Europe. Annu. Rev. Entomol. 1991;36:587–609.
  46. Narankhajid M, Yeruult C, Gurbadam A, Battsetseg J, Aberle S.W, Bayartogtokh B, Joachim A, Duscher G.G. Some aspects on tick species in Mongolia and their potential role in the transmission of equine piroplasms, Anaplasma phagocytophilum and Borrelia burgdorferi L. Parasitol. Res. 2018;117:3557–3566.
    doi: 10.1007/s00436-018-6053-xpubmed: 30178195google scholar: lookup
  47. Fingerle V, Eiffert H, Gessner A, Göbel U, Hofmann H, Hunfeld K, Krause A, Pfister H, Reischl U, Sing A. MiQ 12 Lyme-Borreliose. Qualitätsstandards in der Mikrobiologisch-Infektiologischen Diagnostik. Urban und Fischer/Elsevier; Munich, Germany: 2017.
  48. Priest H.L, Irby N.L, Schlafer D.H, Divers T.J, Wagner B, Glaser A.L, Chang Y.F, Smith M.C. Diagnosis of Borrelia-associated uveitis in two horses. Vet. Ophthalmol. 2012;15:398–405.
  49. Rosa P.A, Schwan T.G. A specific and sensitive assay for the Lyme disease spirochete Borrelia burgdorferi using the polymerase chain reaction. J. Infect. Dis. 1989;160:1018–1029.
    doi: 10.1093/infdis/160.6.1018pubmed: 2584750google scholar: lookup
  50. Krupka I. Infektionen Mit Borrelia burgdorferi sensu lato und Deren Serologischer Nachweis Mittels Spezifischer C6-Peptide bei Hunden Sowie im Murinen Infektionsmodell. Ph.D. Dissertation. Universität Leipzig; Leipzig, Germany: 2010.
  51. Johnson B.J. Lyme Disease: An Evidence-Based Approach. CABI; Wallingford, UK: 2011.
  52. Dattwyler R.J, Volkman D.J, Luft B.J, Halperin J.J, Thomas J, Golightly M.G. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N. Engl. J. Med. 1988;319:1441–1446.
    doi: 10.1056/NEJM198812013192203pubmed: 3054554google scholar: lookup
  53. Gribble D.H. Equine ehrlichiosis. J. Am. Vet. Med. Assoc. 1969;155:462–469.
    pubmed: 5819585
  54. Von Loewenich F, Stumpf G, Baumgarten B, Röllinghoff M, Dumler J, Bogdan C. A case of equine granulocytic ehrlichiosis provides molecular evidence for the presence of pathogenic Anaplasma phagocytophilum (HGE agent) in Germany. Eur. J. Clin. Microbiol. Infect. Dis. 2003;22:303–305.
    doi: 10.1007/s10096-003-0935-1pubmed: 12740667google scholar: lookup
  55. Levi O, Waner T, Baneth G, Keysary A, Bruchim Y, Silverman J, Harrus S. Seroprevalence of Anaplasma phagocytophilum among healthy dogs and horses in Israel. J. Vet. Med. Ser. B. 2006;53:78–80.
  56. Salvagni C.A, Dagnone A.S, Gomes T.S, Mota J.S, Andrade G.M, Baldani C.D, Machado R.Z. Serologic evidence of equine granulocytic anaplasmosis in horses from central West Brazil. Rev. Bras. De Parasitol. Veterinária. 2010;19:135–140.
  57. Madigan J, Hietala S, Chalmers S, DeRock E. Seroepidemiologic survey of antibodies to Ehrlichia equi in horses of northern California. J. Am. Vet. Med. Assoc. 1990;196:1962–1964.
    pubmed: 2195000
  58. Leblond A, Pradier S, Pitel P, Fortier G, Boireau P, Chadoeuf J, Sabatier P. An epidemiological survey of equine anaplasmosis (Anaplasma phagocytophilum) in southern France. Rev. Sci. Et Tech. Int. Off. Epizoot. 2005;24:899–908.
    doi: 10.20506/rst.24.3.1612pubmed: 16642760google scholar: lookup
  59. Maurizi L, Marié J.-L, Courtin C, Gorsane S, Chal D, Davoust B. Seroprevalence survey of equine anaplasmosis in France and in sub-Saharan Africa. Clin. Microbiol. Infect. 2009;15:68–69.
  60. Passamonti F, Fabrizia V, Katia C, Stefano C, Giacomo C, Luisa M.M, Daniela P.F, Andrea V.S, Mauro C. Anaplasma phagocytophilum in horses and ticks: A preliminary survey of Central Italy. Comp. Immunol. Microbiol. Infect. Dis. 2010;33:73–83.
    doi: 10.1016/j.cimid.2008.08.002pubmed: 18805584google scholar: lookup
  61. Butler C, Nijhof A, Jongejan F, Van der Kolk J. Anaplasma phagocytophilum infection in horses in the Netherlands. Vet. Rec. 2008;162:216–217.
    doi: 10.1136/vr.162.7.216pubmed: 18281631google scholar: lookup
  62. Amusategui I, Sainz A, Tesouro M.A. Serological evaluation of Anaplasma phagocytophilum infection in livestock in northwestern Spain. Ann. N. Y. Acad. Sci. 2006;1078:487–490.
    doi: 10.1196/annals.1374.091pubmed: 17114760google scholar: lookup
  63. Praskova I, Bezdekova B, Zeman P, Jahn P. Seroprevalence of Anaplasma phagocytophilum in horses in the Czech Republic. Ticks Tick-Borne Dis. 2011;2:111–115.
    doi: 10.1016/j.ttbdis.2011.01.002pubmed: 21771545google scholar: lookup
  64. Munderloh U.G, Madigan J.E, Dumler J.S, Goodman J.L, Hayes S.F, Barlough J.E, Nelson C.M, Kurtti T.J. Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture. J. Clin. Microbiol. 1996;34:664–670.
    doi: 10.1128/jcm.34.3.664-670.1996pmc: PMC228866pubmed: 8904434google scholar: lookup
  65. Goodman J.L, Nelson C, Vitale B, Madigan J.E, Dumler J.S, Kurtti T.J, Munderloh U.G. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 1996;334:209–215.
    doi: 10.1056/NEJM199601253340401pubmed: 8531996google scholar: lookup
  66. Pusterla N, Huder J.B, Feige K, Lutz H. Identification of a granulocytic Ehrlichia strain isolated from a horse in Switzerland and comparison with other rickettsiae of the Ehrlichia phagocytophila genogroup. J. Clin. Microbiol. 1998;36:2035–2037.
  67. Sells D.M, Hildebrandt P.K, Lewis G.E, Nyindo M.B, Ristic M. Ultrastructural observations on Ehrlichia equi organisms in equine granulocytes. Infect. Immun. 1976;13:273–280.
    doi: 10.1128/iai.13.1.273-280.1976pmc: PMC420604pubmed: 1248873google scholar: lookup
  68. Barlough J.E, Madigan J.E, DeRock E, Bigornia L. Nested polymerase chain reaction for detection of Ehrlichia equi genomic DNA in horses and ticks (Ixodes pacificus). Vet. Parasitol. 1996;63:319–329.
    doi: 10.1016/0304-4017(95)00904-3pubmed: 8966998google scholar: lookup
  69. Pusterla N, Huder J.B, Leutenegger C.M, Braun U, Madigan J.E, Lutz H. Quantitative real-time PCR for detection of members of the Ehrlichia phagocytophila genogroup in host animals and Ixodes ricinus ticks. J. Clin. Microbiol. 1999;37:1329–1331.
  70. Drazenovich N, Foley J, Brown R.N. Use of real-time quantitative PCR targeting the msp2 protein gene to identify cryptic Anaplasma phagocytophilum infections in wildlife and domestic animals. Vector Borne Zoonotic Dis. 2006;6:83–90.
    doi: 10.1089/vbz.2006.6.83pubmed: 16584330google scholar: lookup
  71. Franzén P, Aspan A, Egenvall A, Gunnarsson A, Aberg L, Pringle J. Acute clinical, hematologic, serologic, and polymerase chain reaction findings in horses experimentally infected with a European strain of Anaplasma phagocytophilum. J. Vet. Intern. Med. 2005;19:232–239.
  72. Pusterla N, Madigan J.E. Anaplasma phagocytophilum infection. In: Sellon D.C., Long M.T., editors. Equine Infectious Diseases. Saunders; St. Louis, MI, USA: 2014. pp. 344–347.
  73. Songer J.G, Post K.W. The family Anaplasmataceae. In: Songer J.G., Post K.W., editors. Veterinary Microbiology: Bacterial and Fungal Agents of Animal Disease. Saunders; St. Louis, MI, USA: 2005. pp. 325–326.
  74. Madigan J.E, Gribble D. Equine ehrlichiosis in northern California: 49 cases (1968–1981). J. Am. Vet. Med. Assoc. 1987;190:445–448.
    pubmed: 3558086
  75. Tsachev I, Pantchev N, Marutsov P, Petrov V, Gundasheva D, Baymakova M. Serological Evidence of Borrelia burgdorferi, Anaplasma phagocytophilum and Ehrlichia spp. Infections in Horses from Southeastern Bulgaria. Vector Borne Zoonotic Dis. 2018;18:588–594.
    doi: 10.1089/vbz.2018.2293pubmed: 29969382google scholar: lookup
  76. Tsachev I, Baymakova M, Pantchev N. Seroprevalence of Anaplasma phagocytophilum, Ehrlichia spp. and Borrelia burgdorferi infections in horses: First report from Northern Bulgaria—Short communication. Acta Vet. Hung. 2019;67:197–203.
    doi: 10.1556/004.2019.021pubmed: 31238733google scholar: lookup
  77. Cerri S, Meersschaert C, Houben R, Pitel P.-H, De Waele V, Hendrickx G, Amory H. Diagnostic Value of Serologic Tests and Seroprevalence of Borreliosis in Horses Living in Southern Belgium; Proceedings of the 9th ECEIM Congress; Helsinki, Finland. 3–5 November 2016.
  78. Doby J, Chevrier S, Couatarmanac’h A. Spirochétose à tiques par Borrelia burgdorferi chez le cheval en Bretagne. Résultats d’une enquête sérologique portant sur 400 chevaux. Bull. Soc. Fr. Parasitol. 1987;5:285–295.
  79. Fritz C.I. Retrospektive Betrachtung Serologischer Ergebnisse Verschiedener Borrelien-Antikörper-Nachweisverfahren unter dem Aspekt einer Möglichen Kategorisierung Klinischer Befunde bei Equiden. LMU; Munich, Germany: 2018.
  80. Palm K. Nachweis Spezifischer Antikörper gegen Borrelia Burgdorferi in Equinen Serumproben aus dem Bayerischen Haupt-und Landgestüt Schwaiganger unter Berücksichtigung Aktueller Kriterien der Diagnostik. Ph.D. Dissertation. Ludwig-Maximilians-Universität München; Munich, Germany: 2016.
  81. Wollanke B. Untersuchungen zur Ätiologie der Equinen Rezidivierenden Uveitis. Ph.D. Dissertation. Ludwig-Maximilians-Universität München; Munich, Germany: 1995.
  82. Bartol J. Is Lyme disease overdiagnosed in horses?. Equine Vet. J. 2013;45:529–530.
    doi: 10.1111/evj.12122pubmed: 23909449google scholar: lookup
  83. Divers T.J. Equine lyme disease. J. Equine Vet. Sci. 2013;33:488–492.
  84. Chandrashekar R, Daniluk D, Moffitt S, Lorentzen L, Williams J. Serologic diagnosis of equine borreliosis: Evaluation of an in-clinic enzyme-linked immunosorbent assay (SNAP (R) 4Dx (R)). Int. J. Appl. Res. Vet. Med. 2008;6:145–150.
  85. Chandrashekar R, Mainville C.A, Beall M.J, O’Connor T, Eberts M.D, Alleman A.R, Gaunt S.D, Breitschwerdt E.B. Performance of a commercially available in-clinic ELISA for the detection of antibodies against Anaplasma phagocytophilum, Ehrlichia canis, and Borrelia burgdorferi and Dirofilaria immitis antigen in dogs. Am. J. Vet. Res. 2010;71:1443–1450.
    doi: 10.2460/ajvr.71.12.1443pubmed: 21117995google scholar: lookup
  86. Zöller L, Haude M, Hassler D, Burkard S, Sonntag H. Spontaneous and post-treatment antibody kinetics in late Lyme borreliosis. Serodiagn. Immunother. Infect. Dis. 1989;3:345–353.
  87. Preac Mursic V, Patsouris E, Wilske B, Reinhardt S, Gross B, Mehraein P. Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease. Infection. 1990;18:332–341.
    doi: 10.1007/BF01646399pubmed: 2076905google scholar: lookup
  88. Van Andel A, Magnarelli L, Heimer R, Wilson M. Development and duration of antibody response against Ehrlichia equi in horses. J. Am. Vet. Med. Assoc. 1998;212:1910–1914.
    pubmed: 9638192
  89. Nyindo M, Ristic M, Lewis G, Huxsoll D, Stephenson E. Immune response of ponies to experimental infection with Ehrlichia equi. Am. J. Vet. Res. 1978;39:15–18.
    pubmed: 343663
  90. Franzén P, Aspan A, Egenvall A, Gunnarsson A, Karlstam E, Pringle J. Molecular evidence for persistence of Anaplasma phagocytophilum in the absence of clinical abnormalities in horses after recovery from acute experimental infection. J. Vet. Intern. Med. 2009;23:636–642.
  91. Barthold S.W, Persing D, Armstrong A.L, Peeples R.A. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am. J. Pathol. 1991;139:263.
    pmc: PMC1886084pubmed: 1867318
  92. Krupka I, Bechtel M, Loehnert-Thiel U, Eppendorf R, Straubinger R.K. Borreliose: Möglichkeiten und Perspektiven der Diagnostik. Leipz. Blaue Hefte. 2012:319.
  93. Burgess E, Gendron-Fitzpatrick A. Experimental infection of equines with Borrelia burgdorferi; Proceedings of the Lyme Borreliosis. 1990; Stockholm, Sweden. 18–21 June 1990.
  94. Chang Y.-F, Novosol V, McDonough S, Chang C.-F, Jacobson R, Divers T, Quimby F, Shin S, Lein D. Experimental infection of ponies with Borrelia burgdorferi by exposure to Ixodid ticks. Vet. Pathol. 2000;37:68–76.
    doi: 10.1354/vp.37-1-68pubmed: 10643983google scholar: lookup
  95. Chang Y.-F, Ku Y.-W, Chang C.-F, Chang C.-D, McDonough S.P, Divers T, Pough M, Torres A. Antibiotic treatment of experimentally Borrelia burgdorferi-infected ponies. Vet. Microbiol. 2005;107:285–294.
    doi: 10.1016/j.vetmic.2005.02.006pubmed: 15863289google scholar: lookup
  96. Fahrer H, van der Linden S, Sauvain M.-J, Gern L, Zhioua E, Aeschlimann A. A positive “Lyme-Serology”—What does it mean clinically? Preliminary results of a Swiss prospective study. Lyme Borreliosis II. Zbl Bakt. 1989:329–333.
  97. Satz N. [Immunology and diagnostic test results in Lyme borreliosis]. Schweiz. Med. Wochenschr. 1992;122:1779–1791.
    pubmed: 1448684
  98. Nyarko E, Grab D.J, Dumler J.S. Anaplasma phagocytophilum-infected neutrophils enhance transmigration of Borrelia burgdorferi across the human blood brain barrier in vitro. Int. J. Parasitol. 2006;36:601–605.
    doi: 10.1016/j.ijpara.2006.01.014pubmed: 16600247google scholar: lookup
  99. Beall M.J, Chandrashekar R, Eberts M.D, Cyr K.E, Diniz P.P, Mainville C, Hegarty B.C, Crawford J.M, Breitschwerdt E.B. Serological and molecular prevalence of Borrelia burgdorferi, Anaplasma phagocytophilum, and Ehrlichia species in dogs from Minnesota. Vector Borne Zoonotic Dis. 2008;8:455–464.
    doi: 10.1089/vbz.2007.0236pubmed: 18302532google scholar: lookup
  100. Socoloski S.N.G, de Castro B.G, Cordeiro M.D, da Fonseca A.H, Cepeda M.B, Nicolino R.R, Lopes L.B. Epidemiological investigation of Borrelia burgdorferi in horses in the municipality of Sinop-MT, Brazil. Trop. Anim. Health Prod. 2018;50:831–836.
    doi: 10.1007/s11250-017-1504-4pubmed: 29388162google scholar: lookup
  101. Dzierzecka M, Kita J. The use of chosen serological diagnostic methods in Lyme disease in horses. Part I. Indirect immunofluorescence and enzyme-linked immunosorbent assay (ELISA). Pol. J. Vet. Sci. 2002;5:71–77.
    pubmed: 12189952
  102. Straubinger R.K. Spirochäten. In: Selbitz H.-J., Truyen U., Valentin-Weigand P., editors. Tiermedizinische Mikrobiologie, Infektions-und Seuchenlehre. 10th ed. Enke Verlag; Stuttgart, Germany: 2015.
  103. Littman M.P, Goldstein R.E, Labato M.A, Lappin M.R, Moore G.E. ACVIM small animal consensus statement on Lyme disease in dogs: Diagnosis, treatment, and prevention. J. Vet. Intern. Med. 2006;20:422–434.

Citations

This article has been cited 3 times.
  1. Dorrego A, Olvera-Maneu S, Jose-Cunilleras E, Gago P, Raez A, Rivera B, Oporto A, Gonzalez S, Cruz-Lopez F. Molecular Detection of Theileria equi, Babesia caballi, and Borrelia burgdorferi Sensu Lato in Hippobosca equina from Horses in Spain. Pathogens 2026 Jan 15;15(1).
    doi: 10.3390/pathogens15010094pubmed: 41599078google scholar: lookup
  2. Kloster H, Stormo C, Haaland AH, Stuen S, Kjelland V. Seroprevalence of IgG Antibodies Against Borrelia burgdorferi Sensu Lato, Anaplasma phagocytophilum, and Tick-Borne Encephalitis (TBE) Virus in Horses in Southern Norway. Microorganisms 2025 Mar 28;13(4).
  3. Broeckl CV, Hiereth S, Straubinger RK. A comparative study evaluating three line immunoassays available for serodiagnosis of equine Lyme borreliosis: Detection of Borrelia burgdorferi sensu lato-specific antibodies in serum samples of vaccinated and non-vaccinated horses. PLoS One 2024;19(12):e0316170.
    doi: 10.1371/journal.pone.0316170pubmed: 39715214google scholar: lookup